Cooper Companies (NASDAQ:COO) Research Coverage Started at UBS Group

UBS Group assumed coverage on shares of Cooper Companies (NASDAQ:COO) in a research report sent to investors on Tuesday, Marketbeat reports. The firm issued a neutral rating and a $75.00 target price on the medical device company’s stock.

Other analysts also recently issued research reports about the stock. Mizuho set a $85.00 target price on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, June 4th. Citigroup reaffirmed a “neutral” rating and issued a $76.00 price target (up from $69.00) on shares of Cooper Companies in a report on Wednesday, July 8th. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. BNP Paribas Exane cut their target price on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, June 8th. Finally, Needham & Company LLC cut their target price on Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $81.36.

Cooper Companies Trading Down 0.6%

Cooper Companies stock opened at $72.65 on Tuesday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The stock has a market cap of $14.17 billion, a PE ratio of 61.57, a price-to-earnings-growth ratio of 1.91 and a beta of 0.84. The stock has a 50-day moving average of $68.17 and a two-hundred day moving average of $71.79. Cooper Companies has a one year low of $58.89 and a one year high of $89.83.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company’s revenue was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, research analysts anticipate that Cooper Companies will post 4.63 EPS for the current fiscal year.

Institutional Trading of Cooper Companies

Several institutional investors and hedge funds have recently bought and sold shares of COO. State Street Corp increased its stake in shares of Cooper Companies by 2.4% in the fourth quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock worth $720,736,000 after acquiring an additional 207,195 shares during the period. Wellington Management Group LLP raised its holdings in shares of Cooper Companies by 332.9% during the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after purchasing an additional 4,756,178 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in Cooper Companies by 58.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock valued at $494,123,000 after purchasing an additional 2,231,568 shares during the period. Sustainable Growth Advisers LP lifted its position in Cooper Companies by 22.1% during the third quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock valued at $283,327,000 after purchasing an additional 747,476 shares during the period. Finally, Franklin Resources Inc. boosted its holdings in Cooper Companies by 108.2% in the fourth quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock valued at $329,646,000 after purchasing an additional 2,089,763 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.